Form 8-K - Current report:
SEC Accession No. 0001213900-23-037345
Filing Date
2023-05-08
Accepted
2023-05-08 16:15:28
Documents
19
Period of Report
2023-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea178024-8k_citiuspharma.htm   iXBRL 8-K 38172
2 FORM OF WARRANT ISSUED MAY 8, 2023 ea178024ex4-1_citiuspharma.htm EX-4.1 96475
3 FORM OF PLACEMENT AGENT WARRANT ISSUED MAY 8, 2023 ea178024ex4-2_citiuspharma.htm EX-4.2 95273
4 OPINION OF WYRICK ROBBINS YATES & PONTON, LLP ea178024ex5-1_citiuspharma.htm EX-5.1 11868
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED MAY 3, 2023, BY AND BETWEEN CITIUS ea178024ex10-1_citiuspharma.htm EX-10.1 206139
6 PRESS RELEASE DATED MAY 4, 2023 ea178024ex99-1_citiuspharma.htm EX-99.1 9931
7 PRESS RELEASE DATED MAY 8, 2023 ea178024ex99-2_citiuspharma.htm EX-99.2 8870
8 GRAPHIC ex5-1_001.jpg GRAPHIC 7015
  Complete submission text file 0001213900-23-037345.txt   768694

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ctxr-20230503.xsd EX-101.SCH 2971
10 XBRL LABEL FILE ctxr-20230503_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE ctxr-20230503_pre.xml EX-101.PRE 22367
13 EXTRACTED XBRL INSTANCE DOCUMENT ea178024-8k_citiuspharma_htm.xml XML 3601
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 23897945
SIC: 2834 Pharmaceutical Preparations